http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-SN06387-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02c6622da13b8e6837b41553c20d501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5bdeaf5d6cd3d843430d76efa3887d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cdc92bc1c7b926bba8a2e366f852f52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af52308a393c6b176be2ae4d3cc3373b |
| publicationDate | 2008-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TN-SN06387-A1 |
| titleOfInvention | AMINOPYRIDINE DERIVATIVES AS SELECTIVE DOPAMINE D3 AGONISTS |
| abstract | The present invention provides compounds of formula (I), which represent a class of dopamine agonists, more particularly a class of agonists which are selective for D3 with respect to D2. These compositions are useful for the treatment and / or prevention of sexual dysfunction, for example female sexual dysfunction (FSD), particularly female sexual arousal disorder (FSAD), sexual desire disorder. hypoactive (HSDD, lack of interest in sex), female orgasmic disorder (FOD, failure to achieve orgasm); and male sexual dysfunction, particularly male erectile dysfunction (MED). The term male sexual dysfunction as set forth herein is intended to include ejaculation disorders, such as premature ejaculation, anorgasmia (inability to achieve orgasm) or desire disorders. , such as a hypoactive sexual desire disorder (HSDD, lack of interest in sex). These compounds are also useful in the treatment of neuropsychiatric disorders and neurodegenerative disorders. |
| priorityDate | 2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860 |
Total number of triples: 24.